Pedro Rozas-Moreno

1.1k total citations
32 papers, 879 citations indexed

About

Pedro Rozas-Moreno is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Pedro Rozas-Moreno has authored 32 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Orthopedics and Sports Medicine, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Pedro Rozas-Moreno's work include Bone health and osteoporosis research (17 papers), Bone health and treatments (10 papers) and Bone Metabolism and Diseases (6 papers). Pedro Rozas-Moreno is often cited by papers focused on Bone health and osteoporosis research (17 papers), Bone health and treatments (10 papers) and Bone Metabolism and Diseases (6 papers). Pedro Rozas-Moreno collaborates with scholars based in Spain and Argentina. Pedro Rozas-Moreno's co-authors include Manuel Muñoz‐Torres, Rebeca Reyes‐García, Antonia García‐Martin, Sonia Morales, Beatriz García-Fontana, José A. García‐Salcedo, Mariela Varsavsky, F. Escobar‐Jiménez, Miguel Quesada‐Charneco and Diego Fernández‐García and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Pedro Rozas-Moreno

31 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Rozas-Moreno Spain 13 376 370 203 190 128 32 879
Vikram Vinod Shanbhogue Denmark 14 388 1.0× 651 1.8× 298 1.5× 195 1.0× 143 1.1× 22 1.1k
Pedro Mezquita‐Raya Spain 16 258 0.7× 317 0.9× 147 0.7× 354 1.9× 89 0.7× 31 799
J P Stapleton New Zealand 9 177 0.5× 511 1.4× 318 1.6× 156 0.8× 125 1.0× 11 815
Kamyar Asadipooya United States 13 170 0.5× 232 0.6× 122 0.6× 134 0.7× 52 0.4× 32 699
Dong Won Byun South Korea 15 300 0.8× 117 0.3× 124 0.6× 275 1.4× 128 1.0× 59 816
Subhashini Yaturu United States 15 289 0.8× 176 0.5× 183 0.9× 313 1.6× 149 1.2× 34 976
J. Birmingham Australia 6 190 0.5× 425 1.1× 244 1.2× 108 0.6× 61 0.5× 8 709
R. Rosso Italy 15 214 0.6× 304 0.8× 268 1.3× 112 0.6× 46 0.4× 36 669
Masakazu Notsu Japan 15 242 0.6× 140 0.4× 115 0.6× 151 0.8× 65 0.5× 39 558
E Slatopolsky United States 12 327 0.9× 200 0.5× 234 1.2× 107 0.6× 53 0.4× 14 902

Countries citing papers authored by Pedro Rozas-Moreno

Since Specialization
Citations

This map shows the geographic impact of Pedro Rozas-Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Rozas-Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Rozas-Moreno more than expected).

Fields of papers citing papers by Pedro Rozas-Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Rozas-Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Rozas-Moreno. The network helps show where Pedro Rozas-Moreno may publish in the future.

Co-authorship network of co-authors of Pedro Rozas-Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Rozas-Moreno. A scholar is included among the top collaborators of Pedro Rozas-Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Rozas-Moreno. Pedro Rozas-Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martín, Javier, Cristina Tejera Pérez, José Carlos Fernández‐García, et al.. (2022). Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Endocrinología Diabetes y Nutrición (English ed ). 69(9). 732–743. 3 indexed citations
2.
Reyes‐García, Rebeca, Óscar Moreno, Cristina Tejera Pérez, et al.. (2019). A comprehensive approach to type 2 diabetes mellitus – A recommendation document. Endocrinología Diabetes y Nutrición (English ed ). 66(7). 443–458. 6 indexed citations
3.
Reyes‐García, Rebeca, Óscar Moreno, Cristina Tejera Pérez, et al.. (2019). Documento de abordaje integral de la diabetes tipo 2. Endocrinología Diabetes y Nutrición. 66(7). 443–458. 29 indexed citations
4.
García-Fontana, Beatriz, Francisco Andújar-Vera, Cristina García‐Fontana, et al.. (2018). Circulating levels of sclerostin are associated with cardiovascular mortality. PLoS ONE. 13(6). e0199504–e0199504. 40 indexed citations
5.
Rozas-Moreno, Pedro, et al.. (2017). Recomendaciones sobre el efecto de los fármacos antidiabéticos en el hueso. Endocrinología Diabetes y Nutrición. 64. 1–6. 4 indexed citations
6.
Reyes‐García, Rebeca, et al.. (2016). Hígado graso no alcohólico y diabetes. Medicina Clínica. 148(1). 33–38. 3 indexed citations
7.
García-Fontana, Beatriz, Rebeca Reyes‐García, Sonia Morales, et al.. (2015). Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?. Endocrine. 52(1). 54–62. 48 indexed citations
8.
García-Fontana, Beatriz, Sonia Morales, Caridad Díaz, et al.. (2015). Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study. Talanta. 148. 135–143. 46 indexed citations
9.
Reyes‐García, Rebeca, Antonia García‐Martin, Mariela Varsavsky, et al.. (2015). Actualización de las recomendaciones para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales. Grupo de trabajo de osteoporosis y metabolismo mineral de la SEEN. Endocrinología y Nutrición. 62(5). e47–e56. 12 indexed citations
10.
García‐Martin, Antonia, Rebeca Reyes‐García, Beatriz García-Fontana, et al.. (2014). Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus. PLoS ONE. 9(11). e111703–e111703. 34 indexed citations
11.
Varsavsky, Mariela, et al.. (2013). Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels. Journal of Bone and Mineral Metabolism. 32(1). 65–70. 4 indexed citations
12.
Morales, Sonia, Beatriz García-Fontana, Antonia García‐Martin, et al.. (2013). Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels. Diabetes Care. 36(6). 1667–1674. 113 indexed citations
13.
García‐Martin, Antonia, et al.. (2012). Variables que influyen en las concentraciones de esclerostina en los pacientes con diabetes mellitus tipo 2 y su asociación con el metabolismo óseo. SHILAP Revista de lepidopterología.
14.
García‐Martin, Antonia, et al.. (2011). Role of serum FSH measurement on bone resorption in postmenopausal women. Endocrine. 41(2). 302–308. 39 indexed citations
15.
Varsavsky, Mariela, et al.. (2011). Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer. Endocrinología y Nutrición. 58(9). 487–491. 10 indexed citations
16.
García‐Martin, Antonia, Pedro Rozas-Moreno, Rebeca Reyes‐García, et al.. (2011). Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 97(1). 234–241. 254 indexed citations
17.
Reyes‐García, Rebeca, et al.. (2011). Serum levels of bone resorption markers are decreased in patients with type 2 diabetes. Acta Diabetologica. 50(1). 47–52. 66 indexed citations
18.
Reyes‐García, Rebeca, Pedro Rozas-Moreno, & Manuel Muñoz‐Torres. (2011). Enfermedad cardiovascular, osteoporosis y riesgo de fractura. Revista Clínica Española. 212(4). 188–192. 4 indexed citations
19.
Reyes‐García, Rebeca, Pedro Rozas-Moreno, & Manuel Muñoz‐Torres. (2011). Cardiovascular disease and bone metabolism. Endocrinología y Nutrición (English Edition). 58(7). 353–359. 8 indexed citations
20.
Fernández‐García, Diego, et al.. (2011). Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate. Menopause The Journal of The North American Menopause Society. 19(2). 172–177. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vikram Vinod Shanbhogue Breakdown of academic impact, for papers by Pedro Mezquita‐Raya Breakdown of academic impact, for papers by J P Stapleton Breakdown of academic impact, for papers by Kamyar Asadipooya Breakdown of academic impact, for papers by Dong Won Byun Breakdown of academic impact, for papers by Subhashini Yaturu Breakdown of academic impact, for papers by J. Birmingham Breakdown of academic impact, for papers by R. Rosso Breakdown of academic impact, for papers by Masakazu Notsu Breakdown of academic impact, for papers by E Slatopolsky
Rankless by CCL
2026